NICE (NASDAQ: NICE) reported Q2 EPS of $3.01, $0.02 better than the analyst estimate of $2.99. Revenue for the quarter came in at $726.7 million versus the consensus estimate of $713.27 million.

GUIDANCE:

NICE sees Q3 2025 EPS of $3.12-$3.22, versus the consensus of $3.17. NICE sees Q3 2025 revenue of $722-732 million, versus the consensus of $737 million.

NICE sees FY2025 EPS of $12.33-$12.53, versus the consensus of $12.37. NICE sees FY2025 revenue of $2.92-2.94 billion, versus the consensus of $2.93 billion.

For earnings history and earnings-related data on NICE (NICE) click here.